Ibrutinib Raises Sudden Cardiac Death Risk. 10/13/25

Cardiology Today

Ibrutinib Raises Sudden Cardiac Death Risk. 10/13/25

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

Apple Podcasts Stitcher Spotify

RSS Feed

Share

Link

Embed

Welcome to Cardiology Today – Recorded October 13, 2025. This episode summarizes 5 key cardiology studies on topics like symptomatic atrial fibrillation and coronary sinus pacing. Key takeaway: Ibrutinib Raises Sudden Cardiac Death Risk..

Article Links:

Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. (Heart rhythm)

Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. (Heart rhythm)

Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. (Heart rhythm)

Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients. (Heart rhythm)

Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. (Heart rhythm)

Full episode page: https://podcast.explainheart.com/podcast/ibrutinib-raises-sudden-cardiac-death-risk-10-13-25/

📚 Featured Articles

Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib.

Journal: Heart rhythm

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077373

Summary: Article number one. Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib.

Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study.

Journal: Heart rhythm

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077371

Summary: Article number two. Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study.

Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned.

Journal: Heart rhythm

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077369

Summary: Article number three. Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned.

Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients.

Journal: Heart rhythm

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077368

Summary: Article number four. Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 A.fib Patients.

Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control.

Journal: Heart rhythm

PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077365

Summary: Article number five. Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control.

📝 Transcript

🔍 Keywords

symptomatic atrial fibrillation, coronary sinus pacing, transcatheter tricuspid valve replacement, catheter ablation, rhythm control, clinical outcomes, Bruton’s tyrosine kinase inhibitor, transcatheter edge-to-edge repair, multimorbidity, European Heart Rhythm Association, prognosis, atrial fibrillation, arrhythmias, pulmonary vein isolation, China-A.F. registry, Ibrutinib, sudden cardiac death, cardiac pacing, U.K. Biobank, leadless pacemaker, estimated glucose disposal rate, prospective cohort study, genetic predisposition, early rhythm control, antiarrhythmic drugs, asymptomatic atrial fibrillation, transcatheter tricuspid valve intervention, chronic lymphocytic leukemia, insulin sensitivity.

ℹ️ About

Concise summaries of cardiovascular research for professionals.

Subscribe • Share • Follow